Pharmabiz

Dispatch Bio begins patient dosing in phase 1 study of DISP-10, a novel investigational immunotherapy, in advanced gastrointestinal cancers

Dispatch Bio begins patient dosing in phase 1 study of DISP-10, a novel investigational immunotherapy, in advanced gastrointestinal cancers: Philadelphia, San Francisco Saturday, ...
Pharmabiz

NHA achieves milestone with 25 crore OPD registrations through ABHA-based Scan and Register Service

NHA achieves milestone with 25 crore OPD registrations through ABHA-based Scan and Register Service: Our Bureau, Mumbai In a significant ...
Pharmabiz

Lucid Diagnostics secures commercial coverage policy spanning multiple health plans for its EsoGuard esophageal DNA test

Lucid Diagnostics secures commercial coverage policy spanning multiple health plans for its EsoGuard esophageal DNA test: New York Saturday, August 8, 2026, 13:00 Hrs [IST] Lucid ...
Pharmabiz

Ministry of Ayush takes initiatives to promote production, quality of Ayush medicines

Ministry of Ayush takes initiatives to promote production, quality of Ayush medicines: Our Bureau, Mumbai Saturday, August 8, 2026, 13:30 Hrs [IST] Union Minister of State (I/C) f ...
Pharmabiz

Govt strengthens affordable healthcare ecosystem through NHM, AB PM-JAY: Anupriya Patel

Govt strengthens affordable healthcare ecosystem through NHM, AB PM-JAY: Anupriya Patel: Our Bureau, Mumbai Saturday, August 8, 2026, 13:15 Hrs [IST] Union minister of state for h ...
Pharmabiz

9th India Medical Device 2026 commences in New Delhi

Our Bureau, New Delhi Friday, August 7, 2026, 17:30 Hrs [IST] The two-day 9th edition of India Medical Device 2026 organised ...
Pharmabiz

Mediar Therapeutics inks collaboration and option agreement with Ono Pharma to develop novel treatments for fibro-inflammatory diseases

Mediar Therapeutics inks collaboration and option agreement with Ono Pharma to develop novel treatments for fibro-inflammatory diseases: Boston Saturday, August 8, 2026, 11:00 Hrs ...
Pharmabiz

Priovant initiates patient enrolment in phase 3 study of brepocitinib in cutaneous sarcoidosis

Priovant initiates patient enrolment in phase 3 study of brepocitinib in cutaneous sarcoidosis: Durham, North Carolina Saturday, August 8, 2026, 12:00 Hrs [IST] Priovant, a biotec ...
Pharmabiz

Ractigen Therapeutics completes enrollment and first dosing in phase II trial of RAG-17 for SOD1-ALS

Ractigen Therapeutics completes enrollment and first dosing in phase II trial of RAG-17 for SOD1-ALS: Nantong, China Ractigen Therapeutic ...
Pharmabiz

UK MHRA grants marketing authorization to Novartis Rhapsido for adult patients with CSU with inadequate response to H1 antihistamine

UK MHRA grants marketing authorization to Novartis Rhapsido for adult patients with CSU with inadequate response to H1 antihistamine: London Saturday, August 8, 2026, 09:00 Hrs [I ...
Pharmabiz

Microbiome therapeutics emerging as future engine of drug discovery & personalized healthcare: Dr Debojyoti Dhar

Microbiome therapeutics emerging as future engine of drug discovery & personalized healthcare: Dr Debojyoti Dhar: Nandita Vijayasimha, Bengaluru Saturday, August 8, 2026, 08:00 Hr ...
Pharmabiz

APPC facing fire over retrospective penalties, portal backlogs, and misuse of statutory powers

APPC facing fire over retrospective penalties, portal backlogs, and misuse of statutory powers: Peethaambaran Kunnathoor, Chennai Saturday, August 8, 2026, 08:00 Hrs [IST] The ong ...